Gail J Maderis - Net Worth and Insider Trading

Gail J Maderis Net Worth

The estimated net worth of Gail J Maderis is at least $18,626 dollars as of 2024-04-27. Gail J Maderis is the Director of Durect Corp and owns about 20,000 shares of Durect Corp (DRRX) stock worth over $18,626. Details can be seen in Gail J Maderis's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gail J Maderis has not made any transactions after 2022-08-12 and currently still holds the listed stock(s).

Transaction Summary of Gail J Maderis

To

Gail J Maderis Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gail J Maderis owns 4 companies in total, including NovaBay Pharmaceuticals Inc (NBY) , Acer Therapeutics Inc (ACER) , and Durect Corp (DRRX) among others .

Click here to see the complete history of Gail J Maderis’s form 4 insider trades.

Insider Ownership Summary of Gail J Maderis

Ticker Comapny Transaction Date Type of Owner
NBY NovaBay Pharmaceuticals Inc 2010-10-05 director
ACER Acer Therapeutics Inc 2011-10-27 director
DRRX Durect Corp 2022-08-12 director
ALLR Allarity Therapeutics Inc 2021-12-20 director

Gail J Maderis Latest Holdings Summary

Gail J Maderis currently owns a total of 1 stock. Gail J Maderis owns 20,000 shares of Durect Corp (DRRX) as of August 12, 2022, with a value of $18,626.

Latest Holdings of Gail J Maderis

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
DRRX Durect Corp 2022-08-12 20,000 0.93 18,626

Holding Weightings of Gail J Maderis


Gail J Maderis Form 4 Trading Tracker

According to the SEC Form 4 filings, Gail J Maderis has made a total of 2 transactions in Durect Corp (DRRX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Durect Corp is the acquisition of 2,520 shares on August 12, 2022, which cost Gail J Maderis around $17,895.

Insider Trading History of Gail J Maderis

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gail J Maderis Trading Performance

GuruFocus tracks the stock performance after each of Gail J Maderis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gail J Maderis is -25.47%. GuruFocus also compares Gail J Maderis's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gail J Maderis within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gail J Maderis's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gail J Maderis

Average Return

-56.36%

Average return per transaction

Outperforming Transactions

0%

0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -12.27 -25.47 -27.09 -56.36
Relative Return to S&P 500(%) -8.62 -19.57 -23.48 -61.56

Gail J Maderis Ownership Network

Ownership Network List of Gail J Maderis

No Data

Ownership Network Relation of Gail J Maderis


Gail J Maderis Owned Company Details

What does NovaBay Pharmaceuticals Inc do?

Who are the key executives at NovaBay Pharmaceuticals Inc?

Gail J Maderis is the director of NovaBay Pharmaceuticals Inc. Other key executives at NovaBay Pharmaceuticals Inc include Interim CFO Tommy Law , President & DERMAdoctor & LLC Jeffrey Kunin , and Chief Product Officer Audrey Kunin .

NovaBay Pharmaceuticals Inc (NBY) Insider Trades Summary

Over the past 18 months, Gail J Maderis made no insider transaction in NovaBay Pharmaceuticals Inc (NBY). Other recent insider transactions involving NovaBay Pharmaceuticals Inc (NBY) include a net sale of 11,921 shares made by Audrey Kunin , and a net sale of 11,921 shares made by Jeffrey Kunin .

In summary, during the past 3 months, insiders sold 0 shares of NovaBay Pharmaceuticals Inc (NBY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 23,842 shares of NovaBay Pharmaceuticals Inc (NBY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 23,842 shares.

NovaBay Pharmaceuticals Inc (NBY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NovaBay Pharmaceuticals Inc Insider Transactions

No Available Data

Gail J Maderis Mailing Address

Above is the net worth, insider trading, and ownership report for Gail J Maderis. You might contact Gail J Maderis via mailing address: 364 Lombard St., San Francisco Ca 94133.

Discussions on Gail J Maderis

No discussions yet.